Skip to main content

Table 3 OS and PFS at 18 months and 24 months using frequentist meta-analysis

From: Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis

Population

OS at 18 m %(95% CI)

PFS at 18 m % (95% CI)

OS at 24 m % (95% CI)

PFS at 24 m (95% CI)

≥3rd line

71.49 (68.68, 74.42)

35.37 (33.15, 37.75)

66.50 (63.54, 69.60)

28.26 (26.15, 30.55)

≥4th line

65.07 (60.84, 69.59)

31.36 (28.30, 34.75)

59.51 (55.12, 64.24)

24.13 (21.29, 27.35)

Representative cohorts ≥3rd line

70.92 (67.71, 74.29)

35.52 (33.16, 38.05)

66.45 (63.08, 69.99)

28.42 (26.18, 30.85)

Representative cohorts ≥4th line

65.07 (60.84, 69.59)

31.36 (28.30, 34.75)

59.51 (55.12, 64.24)

24.13 (21.29, 27.35)